Genetic photodermatosis

Genetic photodermatosis is a broad grouping term (Orphanet code 183490) that encompasses a collection of rare inherited skin disorders characterized by abnormal sensitivity to ultraviolet (UV) radiation or visible light. These conditions result from genetic mutations that impair the skin's ability to protect itself from or repair damage caused by sunlight. The skin is the primary organ system affected, though some subtypes may also involve the eyes, nervous system, or other organs depending on the specific underlying genetic defect. This category includes several well-characterized conditions such as xeroderma pigmentosum (defective DNA repair), the porphyrias (disorders of heme biosynthesis leading to phototoxic porphyrin accumulation), erythropoietic protoporphyria, Cockayne syndrome, trichothiodystrophy, and other photosensitivity syndromes. Key symptoms across these disorders typically include exaggerated sunburn reactions, blistering, erythema, skin fragility, and in some cases increased risk of skin cancers following even minimal sun exposure. Some forms present in infancy or early childhood, while others may manifest later. Treatment approaches vary by specific diagnosis but generally center on strict photoprotection, including avoidance of sun exposure, use of protective clothing, and broad-spectrum sunscreens. Specific therapies exist for certain subtypes — for example, afamelanotide for erythropoietic protoporphyria, or hemin for acute porphyrias. Regular dermatologic surveillance for premalignant and malignant skin lesions is essential in conditions like xeroderma pigmentosum. Genetic counseling is recommended for affected families to clarify the specific diagnosis, inheritance pattern, and recurrence risk.

Common questions about Genetic photodermatosis